Consent form version distribution desk

An MVP, or minimum viable product, is the smallest version that your users can actually work with. It is not a cheap version of the full solution. It is a test, built to answer the questions that decide whether the rest is worth building.

1. Pick the riskiest assumption. Here: will medical practice administrators use it to solve "old consent templates remain in circulation after updates"?
2. Build only what tests it. One team, one use case, a few core modules. People do the rest by hand for now.
3. Run a paid pilot. Agree the acceptance criteria, input limits and reviewer responsibilities before starting.
4. Measure, then decide. Track outdated copies and replacement completion. Then expand, change course or stop, with evidence instead of opinions.

MVP scope for this solution. Costed pilot: Template governance; legal validity and patient consent assessment excluded. Start with one buyer organization and a bounded set of representative inputs. Implement the first two modules: identify form variants; compare version markers. Support the third task through an assisted review queue: locate outdated copies. Handle the remaining required functions manually until validated. Include input upload, source references, user correction, a reviewer approval step and export of consent template distribution record. Authentication, account isolation, deletion controls and basic operational logging are included. Specialized production certification, live write integrations and broader rollout are not included unless explicitly stated.

After the MVP. After paying customers repeatedly accept consent template distribution record, automate draft replacement tasks; track acknowledgments; export distribution evidence. Add one tested read integration, reusable customer configuration and scheduled repeat delivery. Increase supported formats or teams only when evaluation cases and reviewer capacity cover the new scope. Template governance; legal validity and patient consent assessment excluded.

What the build depends on. Evidence coordinates, versioned rules, reviewer decisions and a representative reference set. Measure misses as well as confirmed findings before scaling. Obtain representative authorized inputs, an agreed review rubric and a buyer-side owner. Specific scope: Template governance; legal validity and patient consent assessment excluded.

Pricing to test

Test USD 500-2,000 for a defined audit sample and report. Offer recurring review priced by reviewed items and specialist hours. Software-only access can follow a reliable reviewed service. All prices require validation. For this buyer, package the first sale around audit one form family and the defined consent template distribution record. Record actual review effort before offering a recurring allowance. The commercial pilot fee is distinct from the platform development budget.

Message to test

Prove which approved form version each location holds. Demonstrate the result with audit one form family for medical practice administrators. Use a concrete before-and-after example without promising unmeasured savings.

Where to find buyers

Practice compliance consultants and clinic managers

Lead magnet

Audit one form family

The first 30 days

1. Week 1: interview five prospective buyers from medical practice administrators and inspect how they handle old consent templates remain in circulation after updates.
2. Week 2: prepare audit one form family using authorized or synthetic material.
3. Week 3: share the demonstration through practice compliance consultants and clinic managers and seek one bounded paid pilot.
4. Week 4: measure outdated copies and replacement completion, review delivery effort and ask for a repeat purchase. This is a validation schedule, not a promise that the full product can be built in thirty days.

Paid pilot

Agree the acceptance criteria, input limits and reviewer responsibilities before starting. Run audit one form family and deliver consent template distribution record. Compare outdated copies and replacement completion with the buyer's current process on comparable cases; include corrections, missed issues and reviewer time. Seek payment and repeat use. Stop or revise the scope if data access, accuracy or unit economics fail.

Success metrics

Outdated copies and replacement completion

Retention and expansion

Build repeat use around consent template distribution record. Save approved configurations and review decisions with permission, revisit unresolved exceptions and show progress on outdated copies and replacement completion. Offer a recurring volume allowance after repeat demand; expand to adjacent tasks only when the buyer asks and delivery quality remains acceptable.

Why clients would pick it

A domain-specific review rubric and rights-cleared examples of confirmed defects, false alarms and reviewer reasoning. For this concept, accumulate permissioned examples and reviewer corrections around prove which approved form version each location holds. The durable asset is reliable task-specific execution and trusted customer configuration, not access to a general-purpose AI model.

Alternatives and positioning

Manual reviewers, checklists, generic scanning tools and specialist audit services. Position this concept around prove which approved form version each location holds. Compare it against the customer's current process on the same representative task. This is proposed differentiation; no exhaustive competitor study or uniqueness claim has been established.

Main delivery costs

Document or media processing, model evaluation, expert review, false-positive handling, rechecks and customer-specific rubric calibration. Initial validation additionally budgets for clinical administration review. Track model usage, storage, reviewer minutes, exception handling and customer support per accepted deliverable.